author-photo

Olivier Toutirais

University of Rennes

22

Papers

794

Citations

Citation Trend

Filter By

Papers (10) Sort By

Journal Conference Others

Natalizumab in Multiple Sclerosis Treatment: From Biological Effects to Immune Monitoring

2020 Frontiers in Immunology
Show All
- Source
- Cite
- Save
Citations (9)
Les récepteurs de nectines/ DNAM-1 et CRTAM Immuno-surveillance ou échappement tumoral ?

2014
Show All
- Source
- Cite
- Save
Citations (2)
Stroke and the immune system: from pathophysiology to new therapeutic strategies

2011
Show All
- Source
- Cite
- Save
Citations (0)
Stroke and the immune system: from pathophysiology to new therapeutic strategies

2011 Lancet Neurology
Show All
- Source
- Cite
- Save
Citations (325)
Lymphocytes Tγδ en cancérologie-Des lymphocytes tueurs non conventionnels [Tgammadelta lymphocytes in oncology: unconventional killer lymphocytes].

2010 M S-medecine Sciences
Show All
- Source
- Cite
- Save
Citations (6)
Vγ9Vδ2 T cell-mediated recognition of human solid tumors. Potential for immunotherapy of hepatocellular and colorectal carcinomas

2008 Cancer Immunology, Immunotherapy
Show All
- Source
- Cite
- Save
Citations (83)
Soluble HLA-G molecules impair natural killer/dendritic cell crosstalk via inhibition of dendritic cells.

2008 European Journal of Immunology
Show All
- Source
- Cite
- Save
Citations (77)
Low TCR avidity and lack of tumor cell recognition in CD8 + T cells primed with the CEA-analogue CAP1-6D peptide

2007 Cancer Immunology, Immunotherapy
Show All
- Source
- Cite
- Save
Citations (20)
Constitutive expression of TGF‐bêta1, interleukin‐6 and interleukin‐8 by tumor cells as a major component of immune escape in human ovarian carcinoma

2003 European Cytokine Network
Show All
- Source
- Cite
- Save
Citations (50)
Cytotoxic effector cells with antitumor activity can be amplified ex vivo from biopsies or blood of patients with renal cell carcinoma for cell therapy use

2003 Cancer Immunology, Immunotherapy
Show All
- Source
- Cite
- Save
Citations (6)